Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ATAI Life Sciences N.V. - Common Shares (NQ:ATAI)

6.420 -0.030 (-0.47%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 10,270,014
Open 6.700
Bid (Size) 6.520 (15)
Ask (Size) 6.550 (20)
Prev. Close 6.450
Today's Range 6.280 - 6.750
52wk Range 1.040 - 6.545
Shares Outstanding 166,010,476
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares
Cash, cash equivalents, short-term investments and other liquid assets expected to fund operations into 2029, beyond anticipated top-line results from the first Phase 3 clinical trial of BPL-003 
From atai Life Sciences
Via GlobeNewswire
Why Atai Life Sciences Stock Was So Lively This Week
The company, which focuses on psychedelic-based medicine, had a busy few days on both the regulatory and financing fronts. 
Via The Motley Fool

Performance

YTD
+301.2%
+301.2%
1 Month
+29.7%
+29.7%
3 Month
+81.9%
+81.9%
6 Month
+352.1%
+352.1%
1 Year
+435.0%
+435.0%

More News

Read More
atai Life Sciences Announces Pricing of Public Offering of Common Shares
From atai Life Sciences
Via GlobeNewswire
atai Life Sciences Announces Proposed Public Offering of Common Shares
From atai Life Sciences
Via GlobeNewswire
atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression
From atai Life Sciences
Via GlobeNewswire
Market Momentum: A Diverse Group of Stocks Soar to 52-Week Highs Amidst Shifting Tides
Via MarketMinute
Topics Earnings Economy Intellectual Property
Atai Life Sciences Remains Undervalued, Analyst Initiates With Around 125% Stock Upside
Via Benzinga
Alibaba, Lithium Americas And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
Via Benzinga
Demystifying ATAI Life Sciences: Insights From 5 Analyst Reviews
Via Benzinga
Why Atai Life Sciences Stock Crushed It on Tuesday
Via The Motley Fool
Atai Life Sciences Experimental Depression Drug Shows Sustained Benefit In Treatment-Resistant Patients
Via Benzinga
atai Life Sciences and Beckley Psytech Report Positive Phase 2a Data Demonstrating Improved Outcomes with a Two-Dose Induction Regimen of BPL-003 in Patients with Treatment-Resistant Depression
From atai Life Sciences
Via GlobeNewswire
MissionIRNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Jumps as ARK Invest Buys $49.7M Stake, Trims Roku and Tempus AI
Via Investor Brand Network
Topics Artificial Intelligence
Cathie Wood's Ark Bets Big On Solana Treasury Play: Makes $162M Investment In Brera Holdings As Stock Explodes 225%
Via Benzinga
Topics Artificial Intelligence
atai Life Sciences Awarded Grant from the National Institutes of Health
From atai Life Sciences
Via GlobeNewswire
atai Life Sciences to Participate in September Investor Conferences
From atai Life Sciences
Via GlobeNewswire
Atai Life Sciences Revenue Jumps 163%
Via The Motley Fool
Topics Intellectual Property
atai Life Sciences Reports Second Quarter 2025 Financial Results and Recent Corporate Updates
From atai Life Sciences
Via GlobeNewswire
This IonQ Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Via Benzinga
This Atai Life Sciences Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday
Via Benzinga
Why Is ATAI Life Sciences Stock Trading Lower On Monday?
Via Benzinga
What's going on in today's pre-market session
Via Chartmill
ATAI Life Sciences, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
US Stocks Likely To Open Higher As US-EU Ink Trade Deal: Tesla, Palantir, UnitedHealth In Focus
Via Benzinga
Why Celcuity Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga

Frequently Asked Questions

Is ATAI Life Sciences N.V. - Common Shares publicly traded?
Yes, ATAI Life Sciences N.V. - Common Shares is publicly traded.
What exchange does ATAI Life Sciences N.V. - Common Shares trade on?
ATAI Life Sciences N.V. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for ATAI Life Sciences N.V. - Common Shares?
The ticker symbol for ATAI Life Sciences N.V. - Common Shares is ATAI on the Nasdaq Stock Market
What is the current price of ATAI Life Sciences N.V. - Common Shares?
The current price of ATAI Life Sciences N.V. - Common Shares is 6.420
When was ATAI Life Sciences N.V. - Common Shares last traded?
The last trade of ATAI Life Sciences N.V. - Common Shares was at 10/20/25 04:00 PM ET
What is the market capitalization of ATAI Life Sciences N.V. - Common Shares?
The market capitalization of ATAI Life Sciences N.V. - Common Shares is 1.07B
How many shares of ATAI Life Sciences N.V. - Common Shares are outstanding?
ATAI Life Sciences N.V. - Common Shares has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.